IL10 and parasitic infectious disease: In this context, we identified a series of anti-Q586B2 Nbs that could prevent the protein’s IL-10-inducing capacity and that could reduce first-peak parasitemia and prolong survival when administered to the infection site shortly after parasite inoculation.